Comparison of Lobeglitazone With Pioglitazone as Initial Triple Therapy for Diabetes Management

NCT02315287 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Pioglitazone
DRUG: Lobeglitazone

Sponsor

Seoul National University Bundang Hospital